Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Thom

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Journal of Comparative Effectiveness Research|May 24, 2023
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administrationChristopher G Fawsitt, Howard Thom, Stephane A Regnier, et al.
Pharmacoeconomics|August 18, 2025
Developing a Comprehensive Framework for Cost-Effectiveness Evaluation in Metastatic Castration-Sensitive Prostate Cancer: Insights from a Systematic ReviewChristopher G Fawsitt, Elaine Gallagher, Alka Singh, et al.
Applied Health Economics and Health Policy|August 17, 2021
Costs and Cost-Effectiveness of User-Testing of Health Professionals' Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic Model Based on Voriconazole AdministrationMatthew D Jones, Bryony Dean Franklin, D K Raynor, et al.
Journal of Comparative Effectiveness Research|January 9, 2023
A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancerHimani Aggarwal, Kerigo Ndirangu, Katherine B Winfree, et al.
Rheumatology and Therapy|June 25, 2024
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial SpondyloarthritisWalter P Maksymowych, Howard Thom, Michael F Mørup, et al.
Multiple Sclerosis and Related Disorders|January 25, 2019
Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosisRachael McCool, Katy Wilson, Mick Arber, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 7, 2021
Multilevel and Quasi Monte Carlo Methods for the Calculation of the Expected Value of Partial Perfect InformationWei Fang, Zhenru Wang, Michael B Giles, et al.
BMJ Open|September 19, 2020
Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysisHoward Thom, Jeroen Jansen, Jason Shafrin, et al.
Scientific Reports|November 13, 2025
Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancerHaiyin Wang, Christopher G Fawsitt, Philip Orishaba, et al.
Journal of Medical Economics|April 23, 2024
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in ScotlandMichael F Mørup, Vanessa Taieb, Damon Willems, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Journal of Comparative Effectiveness Research|May 24, 2023
Comparison of indirect treatment methods in migraine prevention to address differences in mode of administrationChristopher G Fawsitt, Howard Thom, Stephane A Regnier, et al.
Pharmacoeconomics|August 18, 2025
Developing a Comprehensive Framework for Cost-Effectiveness Evaluation in Metastatic Castration-Sensitive Prostate Cancer: Insights from a Systematic ReviewChristopher G Fawsitt, Elaine Gallagher, Alka Singh, et al.
Applied Health Economics and Health Policy|August 17, 2021
Costs and Cost-Effectiveness of User-Testing of Health Professionals' Guidelines to Reduce the Frequency of Intravenous Medicines Administration Errors by Nurses in the United Kingdom: A Probabilistic Model Based on Voriconazole AdministrationMatthew D Jones, Bryony Dean Franklin, D K Raynor, et al.
Journal of Comparative Effectiveness Research|January 9, 2023
A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancerHimani Aggarwal, Kerigo Ndirangu, Katherine B Winfree, et al.
Rheumatology and Therapy|June 25, 2024
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial SpondyloarthritisWalter P Maksymowych, Howard Thom, Michael F Mørup, et al.
Multiple Sclerosis and Related Disorders|January 25, 2019
Systematic review and network meta-analysis comparing ocrelizumab with other treatments for relapsing multiple sclerosisRachael McCool, Katy Wilson, Mick Arber, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|July 7, 2021
Multilevel and Quasi Monte Carlo Methods for the Calculation of the Expected Value of Partial Perfect InformationWei Fang, Zhenru Wang, Michael B Giles, et al.
BMJ Open|September 19, 2020
Crizanlizumab and comparators for adults with sickle cell disease: a systematic review and network meta-analysisHoward Thom, Jeroen Jansen, Jason Shafrin, et al.
Scientific Reports|November 13, 2025
Indirect treatment comparisons of darolutamide plus docetaxel and androgen deprivation therapy in patients with metastatic hormone-sensitive prostate cancerHaiyin Wang, Christopher G Fawsitt, Philip Orishaba, et al.
Journal of Medical Economics|April 23, 2024
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in ScotlandMichael F Mørup, Vanessa Taieb, Damon Willems, et al.
Pageof 7